Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$545K Buy
351
+5
+1% +$7.96K 0.04% 343
2026
Q1
$457K Sell
346
-5
-1% -$6.85K 0.03% 328
2025
Q4
$376K Buy
351
+2
+0.6% +$2.09K 0.03% 343
2025
Q3
$338K Buy
349
+27
+8% +$21.2K 0.03% 341
2025
Q2
$258K Buy
322
+20
+7% +$14.4K 0.02% 371
2025
Q1
$209K Hold
302
0.02% 379
2024
Q4
$209K Buy
302
+16
+6% +$11.5K 0.03% 275
2024
Q3
$238K Buy
286
+16
+6% +$14.3K 0.04% 240
2024
Q2
$277K Buy
270
+28
+12% +$26.9K 0.05% 211
2024
Q1
$235K Buy
+242
New +$215K 0.04% 238

Other funds holding ASML

Ethos Financial Group's ASML Position: Q2 2026 in Review

Ethos Financial Group increased its ASML (ASML) stake by 1.4% in Q2 2026, buying an estimated $7.96K and bringing the position to 351 shares worth $545K. The position accounts for 0.04% of the portfolio, ranked #343.

Ethos Financial Group first reported a position in ASML in Q1 2024 and has held it in 10 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Ethos Financial Group held 351 shares of ASML worth $545K as of Q2 2026.
  • Ethos Financial Group bought 5 ASML shares in Q2 2026, an estimated $7.96K.
  • ASML made up 0.04% of Ethos Financial Group's portfolio in Q2 2026, its #343 holding.
  • Ethos Financial Group first reported a position in ASML in Q1 2024 and has held it in 10 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.